Hua Medicine (Shanghai) Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	492.93	255.89	76.61	17.6	-
Revenue	492.93	255.89	76.61	17.6	-
Revenue Growth (YoY)	92.63%	234.02%	335.31%	-	-
Cost of Revenue	212.58	131.17	39.24	9.91	-
Gross Profit	280.36	124.72	37.37	7.69	-
Selling, General & Admin	279.92	269.94	203.9	145.28	134.84
Research & Development	145.32	215.09	171.54	129.53	186.84
Operating Expenses	425.24	485.03	375.44	274.81	321.67
Operating Income	-144.88	-360.31	-338.07	-267.12	-321.67
Interest Expense	-8.15	-8.61	-7.91	-3.67	-3.95
Interest & Investment Income	11.49	13.44	16.51	4.24	5.04
Currency Exchange Gain (Loss)	-4.53	2.02	4.14	26.03	-10.37
Other Non Operating Income (Expenses)	8.93	103.32	114.09	37.27	4.88
EBT Excluding Unusual Items	-137.15	-250.14	-211.23	-203.25	-326.08
Merger & Restructuring Charges	-	-	-	-0.26	-
Other Unusual Items	1,243	-	-	-	0.35
Pretax Income	1,106	-250.14	-211.23	-203.51	-325.73
Earnings From Continuing Operations	1,106	-250.14	-211.23	-203.51	-325.73
Net Income	1,106	-250.14	-211.23	-203.51	-325.73
Net Income to Common	1,106	-250.14	-211.23	-203.51	-325.73
Shares Outstanding (Basic)	988	981	977	967	957
Shares Outstanding (Diluted)	1,004	981	977	967	957
Shares Change (YoY)	2.33%	0.44%	1.07%	0.97%	0.73%
EPS (Basic)	1.12	-0.25	-0.22	-0.21	-0.34
EPS (Diluted)	1.10	-0.25	-0.22	-0.21	-0.34
Free Cash Flow	-	-420.8	879.63	-234.67	-293.18
Free Cash Flow Per Share	-	-0.43	0.90	-0.24	-0.31
Gross Margin	56.88%	48.74%	48.79%	43.69%	-
Operating Margin	-29.39%	-140.80%	-441.28%	-1517.80%	-
Profit Margin	224.44%	-97.75%	-275.73%	-1156.36%	-
Free Cash Flow Margin	-	-164.44%	1148.19%	-1333.44%	-
EBITDA	-130.56	-345.99	-322.24	-254.82	-309.69
EBITDA Margin	-26.49%	-135.21%	-	-	-
D&A For EBITDA	14.32	14.32	15.83	12.3	11.98
EBIT	-144.88	-360.31	-338.07	-267.12	-321.67
EBIT Margin	-29.39%	-140.80%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.